Skip to main content
Advertisement
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • General Statistics
    • Circulation Doodle
      • Doodle Gallery
      • Circulation Cover Doodle
    • → Blip the Doodle
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Bridging Disciplines
    • → Articles Bridging Discplines
    • Cardiovascular Case Series
    • Circulation Supplements
    • ECG Challenge
    • Hospitals of History
      • Hospital Santa Maria del Popolo, Naples, Italy
      • Minneapolis City Hospital
      • Pitié-Salpêtrière Hospital
      • Tufts Medical Center
      • Uppsala University Hospital
      • Vassar Brothers Medical Center (Poughkeepsie, NY)
      • Wroclaw Medical University
    • On My Mind
    • Podcast Archive
      • → Circulation on the Run, FIT Edition
    • → Subscribe to Circulation on the Run
  • Resources
    • Instructions for Authors
      • Accepted Manuscripts
      • Revised Manuscripts
    • → Article Types
    • → General Preparation Instructions
    • → Research Guidelines
    • → How to Submit a Manuscript
    • Journal Policies
    • Permissions and Rights Q&A
    • Submission Sites
    • Circulation CME
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
    • Scientific Sessions 2017
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Cardiovascular Genetics
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Circulation

  • My alerts
  • Sign In
  • Join

  • Facebook
  • Twitter
  • Home
  • About this Journal
    • Editorial Board
    • General Statistics
    • Circulation Doodle
    • → Blip the Doodle
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Bridging Disciplines
    • → Articles Bridging Discplines
    • Cardiovascular Case Series
    • Circulation Supplements
    • ECG Challenge
    • Hospitals of History
    • On My Mind
    • Podcast Archive
    • → Subscribe to Circulation on the Run
  • Resources
    • Instructions for Authors
    • → Article Types
    • → General Preparation Instructions
    • → Research Guidelines
    • → How to Submit a Manuscript
    • Journal Policies
    • Permissions and Rights Q&A
    • Submission Sites
    • Circulation CME
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
    • Scientific Sessions 2017
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Cardiovascular Genetics
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association

Search for author "A. Michael Lincoff"

  • Modify Search
  • Create Alert
  • Save Search

79 Results

Type a term to search within all articles in this journal: e.g., stem cell
Content Type
Select types of content to include in the results.
Citation
Citation-specific search information
e.g., 2009
e.g., 20
e.g., 3
e.g., 29
e.g., 10.9999/123XYZ456
Authors, Keywords
Search for specific authors and/or words and phrases.
e.g., Smith, JS
e.g., Smith, JS
Type any phrase that appears in the article title
Type any phrase that appears within article title or abstract
Type any phrase that appears within article body, title or abstract
e.g., Smith, JS
Book publisher name
Limit Results
Limit search results by date
e.g., 07/28/2017
e.g., 07/28/2017
Format Results
  • You have accessRestricted access
    Administration of Recombinant P-Selectin Glycoprotein Ligand Fc Fusion Protein Suppresses Inflammation and Neointimal Formation in Zucker Diabetic Rat Model
    Zhongmin Zhou, Marc S. Penn, Farhad Forudi, Xiaorong Zhou, Khaldoun Tarakji, Eric J. Topol, A. Michael Lincoff and Kai Wang
    Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:1598-1603, originally published August 8, 2002
    https://doi.org/10.1161/01.ATV.0000032676.20514.8F
    Download PDF
  • You have access
    Administration of Recombinant P-Selectin Glycoprotein Ligand Fc Fusion Protein Suppresses Inflammation and Neointimal Formation in Zucker Diabetic Rat Model
    Zhongmin Zhou, Marc S. Penn, Farhad Forudi, Xiaorong Zhou, Khaldoun Tarakji, Eric J. Topol, A. Michael Lincoff, Kai Wang
    Arteriosclerosis, Thrombosis, and Vascular Biology October 2002, 22 (10) 1598-1603; DOI: https://doi.org/10.1161/01.ATV.0000032676.20514.8F
    Figure 1. Photomicrographs of representative P-selectin immunostaining showing arteries fro...
    Show More
    Figure 1. Photomicrographs of representative P-selectin immunostaining showing arteries from control and rPSGL-treated rats at 1, 3, and 7 days after balloon injury. A, Section from rat at day 1 showed positive P-selectin immunostaining. B, Section from rat at day 3 showed P-selectin staining around lumen. C, By day 7, more intense P-selectin staining was observed around lumen and extending into media. D through F, Sections from days 1, 3, and 7 in rPSGL-Ig–treated rats, showing significantly decreased P-selectin expression.
    Show Less
  • You have access
    Administration of Recombinant P-Selectin Glycoprotein Ligand Fc Fusion Protein Suppresses Inflammation and Neointimal Formation in Zucker Diabetic Rat Model
    Zhongmin Zhou, Marc S. Penn, Farhad Forudi, Xiaorong Zhou, Khaldoun Tarakji, Eric J. Topol, A. Michael Lincoff, Kai Wang
    Arteriosclerosis, Thrombosis, and Vascular Biology October 2002, 22 (10) 1598-1603; DOI: https://doi.org/10.1161/01.ATV.0000032676.20514.8F
    View table
    Table 1.
    % Area Occupied by P-Selectin Positive Cells After Balloon Injury
    Show More
    % Area Occupied by P-Selectin Positive Cells After Balloon Injury
    Show Less
  • You have access
    Administration of Recombinant P-Selectin Glycoprotein Ligand Fc Fusion Protein Suppresses Inflammation and Neointimal Formation in Zucker Diabetic Rat Model
    Zhongmin Zhou, Marc S. Penn, Farhad Forudi, Xiaorong Zhou, Khaldoun Tarakji, Eric J. Topol, A. Michael Lincoff, Kai Wang
    Arteriosclerosis, Thrombosis, and Vascular Biology October 2002, 22 (10) 1598-1603; DOI: https://doi.org/10.1161/01.ATV.0000032676.20514.8F
    Figure 2. Photomicrographs of representative CD45 immunostaining showing arteries from cont...
    Show More
    Figure 2. Photomicrographs of representative CD45 immunostaining showing arteries from control and rPSGL–treated rats at 1, 3, and 7 days after balloon injury. A, Section from control rat at day 1 showed intense CD45 immunostaining. B, Section from control rat at day 3 showed CD45 staining around lumen. C, By day 7, control rat sections still had intense CD45 staining, observed around lumen and extending into media. D through F, Much less CD45 immunostaining was observed in rPSGL–treated rat at days 1, 3, and 7.
    Show Less
  • You have access
    Administration of Recombinant P-Selectin Glycoprotein Ligand Fc Fusion Protein Suppresses Inflammation and Neointimal Formation in Zucker Diabetic Rat Model
    Zhongmin Zhou, Marc S. Penn, Farhad Forudi, Xiaorong Zhou, Khaldoun Tarakji, Eric J. Topol, A. Michael Lincoff, Kai Wang
    Arteriosclerosis, Thrombosis, and Vascular Biology October 2002, 22 (10) 1598-1603; DOI: https://doi.org/10.1161/01.ATV.0000032676.20514.8F
    View table
    Table 2.
    % Area Occupied by CD45 Positive Leukocytes After Balloon Injury
    Show More
    % Area Occupied by CD45 Positive Leukocytes After Balloon Injury
    Show Less
  • You have access
    Administration of Recombinant P-Selectin Glycoprotein Ligand Fc Fusion Protein Suppresses Inflammation and Neointimal Formation in Zucker Diabetic Rat Model
    Zhongmin Zhou, Marc S. Penn, Farhad Forudi, Xiaorong Zhou, Khaldoun Tarakji, Eric J. Topol, A. Michael Lincoff, Kai Wang
    Arteriosclerosis, Thrombosis, and Vascular Biology October 2002, 22 (10) 1598-1603; DOI: https://doi.org/10.1161/01.ATV.0000032676.20514.8F
    View table
    Table 3.
    Morphometric Results
    Show More
    Morphometric Results
    Show Less
  • You have access
    Administration of Recombinant P-Selectin Glycoprotein Ligand Fc Fusion Protein Suppresses Inflammation and Neointimal Formation in Zucker Diabetic Rat Model
    Zhongmin Zhou, Marc S. Penn, Farhad Forudi, Xiaorong Zhou, Khaldoun Tarakji, Eric J. Topol, A. Michael Lincoff, Kai Wang
    Arteriosclerosis, Thrombosis, and Vascular Biology October 2002, 22 (10) 1598-1603; DOI: https://doi.org/10.1161/01.ATV.0000032676.20514.8F
    Figure 3. Photomicrographs of carotid arteries 21 days after balloon injury (Movat, ×5). A,...
    Show More
    Figure 3. Photomicrographs of carotid arteries 21 days after balloon injury (Movat, ×5). A, Representative light microscopy of cross section of injured carotid artery from rPSGL treatment group showing reduced neointimal hyperplasia with large luminal area. B, Representative light microscopy of cross section of injured carotid artery from control group showing extensive neointimal hyperplasia with smaller luminal area.
    Show Less
  • You have accessRestricted access
    Administration of Recombinant P-Selectin Glycoprotein Ligand Fc Fusion Protein Suppresses Inflammation and Neointimal Formation in Zucker Diabetic Rat Model
    Zhongmin Zhou, Marc S. Penn, Farhad Forudi, Xiaorong Zhou, Khaldoun Tarakji, Eric J. Topol, A. Michael Lincoff and Kai Wang
    Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:1598-1603, originally published August 8, 2002
    https://doi.org/10.1161/01.ATV.0000032676.20514.8F
    Download PDF
  • You have access
    Administration of Recombinant P-Selectin Glycoprotein Ligand Fc Fusion Protein Suppresses Inflammation and Neointimal Formation in Zucker Diabetic Rat Model
    Zhongmin Zhou, Marc S. Penn, Farhad Forudi, Xiaorong Zhou, Khaldoun Tarakji, Eric J. Topol, A. Michael Lincoff, Kai Wang
    Arteriosclerosis, Thrombosis, and Vascular Biology October 2002, 22 (10) 1598-1603; DOI: https://doi.org/10.1161/01.ATV.0000032676.20514.8F
    Figure 1. Photomicrographs of representative P-selectin immunostaining showing arteries fro...
    Show More
    Figure 1. Photomicrographs of representative P-selectin immunostaining showing arteries from control and rPSGL-treated rats at 1, 3, and 7 days after balloon injury. A, Section from rat at day 1 showed positive P-selectin immunostaining. B, Section from rat at day 3 showed P-selectin staining around lumen. C, By day 7, more intense P-selectin staining was observed around lumen and extending into media. D through F, Sections from days 1, 3, and 7 in rPSGL-Ig–treated rats, showing significantly decreased P-selectin expression.
    Show Less
  • You have access
    Administration of Recombinant P-Selectin Glycoprotein Ligand Fc Fusion Protein Suppresses Inflammation and Neointimal Formation in Zucker Diabetic Rat Model
    Zhongmin Zhou, Marc S. Penn, Farhad Forudi, Xiaorong Zhou, Khaldoun Tarakji, Eric J. Topol, A. Michael Lincoff, Kai Wang
    Arteriosclerosis, Thrombosis, and Vascular Biology October 2002, 22 (10) 1598-1603; DOI: https://doi.org/10.1161/01.ATV.0000032676.20514.8F
    View table
    Table 1.
    % Area Occupied by P-Selectin Positive Cells After Balloon Injury
    Show More
    % Area Occupied by P-Selectin Positive Cells After Balloon Injury
    Show Less

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 8
  • Next Page
Back to top

Selected Facets

Selected Facets

  • 1978 - 2002 (Publication date)

Journal

Source

  • Arteriosclerosis, Thrombosis, and Vascular Biology 24
  • Circulation Research 1
  • Circulation 54

Article Type

Article Type

  • Acute coronary syndromes 5
  • Antiplatelets 5
  • Article 7
  • Basic Science Reports 1
  • Brief Rapid Communications 3
  • Clinical Investigation and Reports 43
  • Clinical Investigation and Reports* 1
  • Growth factors/cytokines 7
  • In Vitro 1
  • Journal Article 2
  • Other Vascular biology 7
  • Other anticoagulants 5
  • Research Support, Non-U.S. Gov't 1
  • Research Support, U.S. Gov't, P.H.S. 1
  • Review 2
  • Thrombosis 10
  • Type 2 diabetes 7
  • Vascular Biology 14
  • Show More
  • Show Less

Subject

Subject

  • Acute coronary syndromes 20
  • Acute myocardial infarction 4
  • Animal models of human disease 1
  • Anticoagulant mechanisms 9
  • Antiplatelets 10
  • Arterial thrombosis 8
  • Cardiovascular Pharmacology 17
  • Catheter-based coronary and valvular interventions: other 6
  • Catheter-based coronary interventions: stents 8
  • Chronic ischemic heart disease 8
  • Coagulation 9
  • Coagulation inhibitors 8
  • Coronary imaging: angiography/ultrasound/Doppler/CC 2
  • Growth factors/cytokines 14
  • Health policy and outcome research 1
  • Other Treatment 1
  • Other Vascular biology 14
  • Other anticoagulants 18
  • Other diagnostic testing 1
  • Pathophysiology 1
  • Platelet function inhibitors 4
  • Platelets 7
  • Receptor pharmacology 1
  • Restenosis 13
  • Risk Factors for Stroke 1
  • Secondary prevention 1
  • Thrombin 8
  • Type 2 diabetes 15
  • Show More
  • Show Less

Content Type

Resource Type

  • Articles 39
  • Tables & Figures 29
  • HWTABLE 11
Advertisement
Advertisement

Circulation

  • About Circulation
  • Instructions for Authors
  • Circulation CME
  • Statements and Guidelines
  • Meeting Abstracts
  • Permissions
  • Journal Policies
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
200 Fifth Avenue, Suite 1020
Waltham, MA 02451
email: circ@circulationjournal.org
 

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2017 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured